Morphine (MOR) Hair Rapid Test

Morphine is a prescription opioid medicine used for severe pain management under medical supervision. It may be used in serious pain conditions, post-surgical pain, cancer pain, trauma-related pain, or other cases where strong opioid therapy is medically required. From a drug screening point of view, morphine is important because it may appear due to prescribed medical use, misuse, or exposure to opioid-related substances.

• Hair testing is useful when a longer history of possible drug exposure is required. Compared with urine or saliva testing, hair testing may provide a broader detection window.
• A Morphine MOR Hair Rapid Test can support workplace screening, rehabilitation monitoring, forensic screening, clinical toxicology, compliance testing, and international diagnostic distribution.
• The MOR Hair Rapid Test does not diagnose addiction, overdose, intoxication, or any medical condition. It only provides a preliminary screening result for morphine in hair specimens at the stated cut-off.

The Morphine (MOR) Hair Rapid Test by LARKSOIS Pharma may be used in professional diagnostic and institutional screening environments.

Applications

• Drug of abuse screening programs
• Workplace and pre-employment testing support
• Rehabilitation and de-addiction monitoring
• Clinical toxicology screening
• Forensic and compliance screening
• Longer-window opioid exposure assessment
• International diagnostic distribution
• Laboratory and professional screening workflows

The Morphine (MOR) Hair Rapid Test uses a rapid screening method for qualitative detection of morphine-related opioid exposure in hair specimens. It is designed to provide a preliminary screening result at the stated 20 ng/mL cut-off.

Benefits

• Hair-based rapid screening format
• 20 ng/mL morphine cut-off
• Designed for MOR / morphine drug screening
• Suitable for professional diagnostic use
• Supports longer-window screening programs
• Useful for clinical, workplace, rehabilitation, forensic, and institutional workflows
• Applicable for laboratories, hospitals, diagnostic centers, and distributors
• Supports international drug screening requirements

The Morphine (MOR) Rapid Test is designed for hair specimens. Hair testing is useful when longer-window screening is required and may support professional programs where historical exposure information is important.

Guidance

• Use hair specimens only
• Follow the product insert carefully
• Collect and prepare the hair specimen according to the approved method
• Avoid contaminated or improperly handled samples
• Interpret results within the stated reading window
• Use confirmatory testing where required by clinical, legal, workplace, forensic, or institutional policy

Note

Hair testing does not prove current intoxication. A rapid screening result should be considered preliminary unless confirmed by a validated laboratory method where required.

The Morphine (MOR) Hair Rapid Test by LARKSOIS Pharma has a stated cut-off of 20 ng/mL. This means the test is designed to screen prepared hair specimens for morphine at or above the validated threshold. LARKSOIS Pharma should mention the exact performance details according to the final product insert, technical file, and regulatory documentation.

Instructions

• Hair-based morphine drug abuse screening
• 20 ng/mL cut-off for professional screening needs
• Simple rapid test format
• Suitable for longer-window screening programs
• Useful for workplace, clinical, forensic, and rehabilitation settings
• Supports drug of abuse testing panels
• Designed for international diagnostic distribution
• Manufactured with LARKSOIS Pharma quality focus

Note

The Morphine MOR Hair Rapid Test by LARKSOIS Pharma is created for professional users who need a practical, efficient, and reliable preliminary screening solution.

Steps

• Bring the test device and hair specimen preparation materials to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect the hair specimen according to the approved collection method
• Prepare the hair specimen according to the product insert
• Apply the processed specimen according to the test instructions
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Morphine (MOR) Hair Rapid Test.

Positive

A positive or non-negative result suggests that morphine-related opioid markers may be present in the processed hair specimen at or above the stated cut-off. Positive results are preliminary and should be confirmed using a recognized laboratory method where required.

Negative

A negative result suggests that morphine-related markers were not detected or were below the cut-off at the time of testing. A negative result does not always rule out exposure if sample quality, collection method, or detection window affects the result.

Invalid

If the valid control indicator does not appear, the test is invalid. The test should be repeated with a new device and properly prepared hair specimen according to the product insert.

Instructions

• Store according to the product label and package insert
• Keep the test sealed until use
• Protect it from direct sunlight, moisture, and extreme temperatures
• Do not use expired or damaged test devices
• Use only approved specimen preparation materials
• Read results only within the stated time
• Do not reuse the test device

Instructions

• For professional screening use only
• Use hair specimen only as directed
• Do not reuse the test device
• Follow the product insert carefully
• Handle all specimens with standard safety precautions
• Do not interpret results after the recommended reading time
• Confirm presumptive positive results with laboratory testing
• Follow applicable drug testing laws and reporting requirements

LARKSOIS Pharma provides internationally focused pharmaceutical and diagnostic products for professional healthcare and screening markets. The Morphine MOR Hair Rapid Test is developed for distributors, laboratories, hospitals, rehabilitation centers, workplace testing providers, forensic programs, and global diagnostic buyers.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for laboratories and healthcare suppliers
• Distributor-friendly product format
• Supports drug of abuse screening programs
• Designed for practical hair specimen screening workflows
• Quality-focused standards under LARKSOIS Pharma